CymaBay Therapeutics Inc (NASDAQ:CBAY)

13.45
Delayed Data
As of Jul 17
 +0.48 / +3.70%
Today’s Change
5.50
Today|||52-Week Range
15.59
+46.20%
Year-to-Date
New Strong Sell Stocks for July 11th
Jul 11 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close12.97
Today’s open12.88
Day’s range12.64 - 13.50
Volume659,727
Average volume (3 months)1,059,034
Market cap$685.8M
Data as of 4:00pm ET, 07/17/2018

Growth & Valuation

Earnings growth (last year)+30.70%
Earnings growth (this year)-50.16%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales32.11
Price/Book6.10

Competitors

 Today’s
change
Today’s
% change
ACETAceto Corp+0.14+4.28%
DITAMCON Distributing C...+1.00+1.22%
AGXArgan Inc0.000.00%
NUSNU Skin Enterprises ...+0.40+0.53%
Data as of 4:02pm ET, 07/17/2018

Financials

Next reporting dateAugust 8, 2018
EPS forecast (this quarter)-$0.25
Annual revenue (last year)$10.0M
Annual profit (last year)-$27.6M
Net profit margin-275.57%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Sujal Shah
Chief Scientific Officer &
Senior Vice President
Charles A. McWherter
Corporate headquarters
Newark, California

Forecasts